Tenderwize
Back to tender search

Open House Originale Contract for Sofosbuvir/Velpatasvir/Voxilaprevir

Techniker Krankenkasse·Hamburg, Germany·Deadline Aug 30, 2027 · 376 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-21 - Sofosbuvir, Velpatasvir, Voxilaprevir (Wirkstoffkombination)

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Offers/contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature...

Only pharmaceutical undertakings for the relevant medicines, with the required seat and marketing authorisation, may pa...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Supply/rebate contract for pharmaceutical products concerning the combination Sofosbuvir, Velpatasvir, Voxilaprevir.
  • Nationwide performance in Germany.
Show full summary

Open House-style pharmaceutical supply arrangement by Techniker Krankenkasse for the fixed combination Sofosbuvir/Velpatasvir/Voxilaprevir. The notice states there is no exclusivity, no individual negotiation, and contracts can be joined at any time during the term. The contract term runs from 2025-09-01 to 2027-08-31 at the latest, with earlier automatic end if patent/market exclusivity expires. No contract value is stated. Participation is restricted to pharmaceutical companies meeting the stated legal and self-declaration requirements, and submission is not via the portal but by email or post.

Risks

Offers/contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature...

Only pharmaceutical undertakings for the relevant medicines, with the required seat and marketing authorisation, may pa...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the relevant medicines.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicines or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Contract for Sofosbuvir/Velpatasvir/Voxilaprevir

Single lot covering rebate contracts for the medicinal product combination Sofosbuvir, Velpatasvir, Voxilaprevir. Scope is nationwide in Germany. The notice says the arrangement is open to all suitable pharmaceutical companies, with uniform conditions, no exclusivity, and no individual negotiations. The lot information comes from structured data and the XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Deadline

Deadline Aug 30, 2027

Procurement Details

Publication date
22 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
481017-2025

Documents (1)

Similar tenders